What we do / HEOR & market access
Partnering to improve patient outcomes through innovative, robust, evidence-based solutions
Choose a partner that has been at the forefront of HEOR through the development and application of innovative solutions to ensure better and faster access for patients, leading to commercial success.
Our multidisciplinary teams have a deep knowledge of global market access challenges and apply the highest scientific standards to our research to communicate a product’s value.
Our services
We support our clients with technical and strategic expertise in the following areas:
Global Market access strategy
We provide comprehensive strategic market access solutions, including global payer strategy, HTA strategy and submissions, evidence synthesis, and value communications, to help you navigate the ever-evolving global market access landscape.
Health economic modeling & meta-analysis
We provide an unrivaled mix of health economics and outcome technical expertise and strategic insights in the field of health-economic modeling and evidence synthesis. With our bespoke approach, we work with you to assess your needs and develop the most fit-for-purpose solution.
Patient-centered outcomes
We develop, refine, and analyze outcomes, quantify values, and optimize study designs to measure the outcomes that matter most to patients. From patient-reported outcomes to clinical outcomes assessment instrument development and selection for trials, we have the technical, strategic, and communications skills to support your team.
Real-world evidence & data analytics
We leverage data from diverse sources to answer questions about disease epidemiology, burden, treatment patterns, comparative effectiveness, and costs. We are experts at generating new data via different methodologies and using data from multiple sources.
Our global HEOR expertise
1000
publications in 24 therapy areas
30
years of innovation
800
posters in 22 therapy areas
250
HTA submissions supported worldwide
A collection of our research is backed by the Scientific Buyout Fund
The OPEN Health Scientific Buyout Program is aimed at empowering scientific and technical staff within the HEOR & Market Access team to “buy out” time from their regular duties to engage in important scientific projects, including developing manuscripts, exploring new methodologies, conducting research, and preparing conference presentations. Look for the “Funded by the Scientific Office” stamp at ISPOR EU and other international conferences emphasizing the support behind these projects.
Get in touch on HEOR consulting solutions
To learn more about our HEOR consulting or Global Market Access capabilities and discuss what we could do for you, please get in touch.
Explore related content
Services
Company
Legal and Governance
